Table 2 Determination of prognostic clinical factors
Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (years, mean ± SD) | 0.989 (0.971–1.006) | 1.937E−01 | NA | NA |
Gender (Male/Female) | 1.630 (1.030–2.579) | 3.521E−02* | 1.567 (0.984–2.495) | 5.872E−02 |
Pathologic M (M0/M1/−) | 3.498 (2.015–6.072) | 2.162E−06* | 2.358 (0.870–6.391) | 9.165E−02 |
Pathologic N (N0/N1/N2) | 0.909 (0.537–1.540) | 7.226E−01 | NA | NA |
Pathologic T (T1/T2/T3/T4) | 2.310 (1.484–3.597) | 3.167E−04* | 1.552 (0.909–2.649) | 1.070E−01 |
Pathologic stage (I/II/III/IV/−) | 1.849 (1.423–2.402) | 2.874E−06* | 1.482 (1.105–1.986) | 8.541E−03* |
lncRNA RS model (High/Low) | 2.925 (1.773–4.825) | 1.062E−05* | 2.438 (1.443–4.118) | 8.610E−04* |
Recurrence (Yes/No) | NA | NA | NA | NA |
Recurrence free survival time (months, mean ± SD) | NA | NA | NA | NA |